Paul H Coluzzi

Title(s)Health Sciences Professor, Medicine
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-5153
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Electroacupuncture for the management of symptom clusters in cancer patients and survivors (EAST). BMC Complement Med Ther. 2023 Mar 27; 23(1):92. Xie L, Ng DQ, Heshmatipour M, Acharya M, Coluzzi P, Guerrero N, Lee S, Malik S, Parajuli R, Stark C, Tain R, Zabokrtsky K, Torno L, Chan A. PMID: 36973688; PMCID: PMC10041509.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies. Support Care Cancer. 2021 Sep; 29(9):5209-5218. Brenner DM, Slatkin NE, Stambler N, Israel RJ, Coluzzi PH. PMID: 33629189; PMCID: PMC8295095.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus. Ther Adv Med Oncol. 2020; 12:1758835920967259. Peddi PF, Tetef M, Coluzzi P, Arzoo KK, Hu EH, Berkowitz MJ, Chan D, Moore D, Adams B, Wang X, Hurvitz SA. PMID: 33299473; PMCID: PMC7711222.
      View in: PubMed   Mentions:
    4. A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC. J Thorac Oncol. 2018 08; 13(8):1138-1145. Lisberg A, Cummings A, Goldman JW, Bornazyan K, Reese N, Wang T, Coluzzi P, Ledezma B, Mendenhall M, Hunt J, Wolf B, Jones B, Madrigal J, Horton J, Spiegel M, Carroll J, Gukasyan J, Williams T, Sauer L, Wells C, Hardy A, Linares P, Lim C, Ma L, Adame C, Garon EB. PMID: 29874546; PMCID: PMC6063769.
      View in: PubMed   Mentions: 226     Fields:    Translation:HumansCTClinical Trials
    5. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain. 2001 Mar; 91(1-2):123-30. Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA, Chavez J, Ashley J, Lebo D, McCracken M, Portenoy RK. PMID: 11240084.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    6. Survey of analgesic use for nonmalignant pain in long-term care facilities in southern California. J Am Med Dir Assoc. 2000 May-Jun; 1(3):109-13. Fujimoto D, Coluzzi PH. PMID: 12818022.
      View in: PubMed   Mentions: 1     Fields:    
    7. A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A. Cancer Chemother Pharmacol. 2000; 46(5):403-10. Raschko JW, Synold TW, Chow W, Coluzzi P, Hamasaki V, Leong LA, Margolin KA, Morgan RJ, Shibata SI, Somlo G, Tetef ML, Yen Y, ter Veer A, Doroshow JH. PMID: 11127945.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    8. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up. Gynecol Oncol. 1999 Dec; 75(3):419-26. Morgan RJ, Braly P, Cecchi G, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Parker P, Stein A, Cho J, Smith E, Coluzzi P, Najera L, Johnson D, Womack E, Doroshow JH. PMID: 10600300.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    9. The management of pain in terminally ill cancer patients with difficulty swallowing. Am J Hosp Palliat Care. 1999 Nov-Dec; 16(6):731-7. Coluzzi PH, Fairbairn BS. PMID: 11094910.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain. 1999 Feb; 79(2-3):303-12. Portenoy RK, Payne R, Coluzzi P, Raschko JW, Lyss A, Busch MA, Frigerio V, Ingham J, Loseth DB, Nordbrock E, Rhiner M. PMID: 10068176.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    11. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol. 1998 Oct; 16(10):3238-45. Christie JM, Simmonds M, Patt R, Coluzzi P, Busch MA, Nordbrock E, Portenoy RK. PMID: 9779697.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    12. Sublingual morphine: efficacy reviewed. J Pain Symptom Manage. 1998 Sep; 16(3):184-92. Coluzzi PH. PMID: 9769621.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    13. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis. Cancer Res. 1998 Jul 01; 58(13):2793-800. Morgan RJ, Newman EM, Doroshow JH, McGonigle K, Margolin K, Raschko J, Chow W, Somlo G, Leong L, Tetef M, Shibata S, Hamasaki V, Carroll M, Vasilev S, Akman S, Coluzzi P, Wagman L, Longmate J, Paz B, Yen Y, Klevecz R. PMID: 9661893.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    14. Managing breakthrough pain. New method expands treatment options. Adv Nurse Pract. 1998 Jan; 6(1):41-3, 68. Rhiner M, Coluzzi PH. PMID: 9495944.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Cancer pain management: newer perspectives on opioids and episodic pain. Am J Hosp Palliat Care. 1998 Jan-Feb; 15(1):13-22. Coluzzi PH. PMID: 9468974.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2337-45. Morgan RJ, Doroshow JH, Venkataraman K, Chang K, Raschko J, Somlo G, Leong L, Tetef M, Shibata S, Hamasaki V, Margolin K, Forman S, Akman S, Coluzzi P, Ahn C, Weiss L, Gadgil U, Harrison J. PMID: 9815632.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    17. Oral patient-controlled analgesia. Semin Oncol. 1997 Oct; 24(5 Suppl 16):S16-35-42. Coluzzi PH. PMID: 9381226.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors. Cancer Chemother Pharmacol. 1997; 39(3):254-8. Newman EM, Carroll M, Akman SA, Chow W, Coluzzi P, Hamasaki V, Leong LA, Margolin KA, Morgan RJ, Raschko JW, Shibata S, Somlo G, Tetef M, Yen Y, Ahn CW, Doroshow JH. PMID: 8996529.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    19. An institutional commitment to pain management. J Clin Oncol. 1995 Sep; 13(9):2158-65. Ferrell BR, Dean GE, Grant M, Coluzzi P. PMID: 7666074.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    20. Survey of the provision of supportive care services at National Cancer Institute-designated cancer centers. J Clin Oncol. 1995 Mar; 13(3):756-64. Coluzzi PH, Grant M, Doroshow JH, Rhiner M, Ferrell B, Rivera L. PMID: 7533828.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    21. 5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial. Cancer Invest. 1995; 13(5):460-3. Tetef M, Doroshow J, Akman S, Coluzzi P, Leong L, Margolin K, Morgan RJ, Raschko J, Shibata S, Somlo G, et al. PMID: 7552810.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    22. Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial. J Cancer Res Clin Oncol. 1995; 121(2):103-6. Tetef M, Margolin K, Ahn C, Akman S, Chow W, Coluzzi P, Leong L, Morgan RJ, Raschko J, Shibata S, et al. PMID: 7883772.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    23. NT, a 64-year-old man, presented in the fall of 1991 with pelvic pain associated with prostatic hypertrophy. Cancer Pract. 1994 Sep-Oct; 2(5):330-4. Niles R, Blum D, Coluzzi PH, Swenson CJ, Miguel R. PMID: 7697070.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Hospital--creating a pain-free environment: a program to improve pain control in hospitalized patients. J Palliat Care. 1993; 9(2):50. Coluzzi P. PMID: 8377073.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Lymphocyte receptors for polyclonal T mitogens. I. Concanavalin A binding to lymphocytes inhibits mitogenesis induced by galactose oxidase. Cell Immunol. 1982 Mar 15; 68(1):25-37. Gordon IL, Coluzzi PH, Favero JJ, Parker JW, O'Brien RL. PMID: 7083339.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Paul's Networks
    Concepts (130)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (16)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-2-gbbe5f151 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California